Skip to main content
. 2022 Aug 5;11(15):4574. doi: 10.3390/jcm11154574

Table 3.

Datasets (train and test sets) used in predicting hospitalization in patients with respiratory symptoms during the COVID-19 pandemic.

Characteristic Train
n = 5868
Test
n = 1468
Female sex 3102 (53%) 792 (54%)
Age 41 (29, 53) 40 (30, 54)
Symptom duration 4 (2, 8) 4 (2, 8)
Systolic blood pressure 133 (121, 147) 132 (120, 145)
Diastolic blood pressure 84 (74, 94) 82 (74, 92)
Heart rate 90 (80, 102) 89 (80, 100)
Temperature 36.50 (36.00, 36.80) 36.50 (36.00, 36.70)
Respiratory frequency 18 (17, 20) 18 (17, 20)
SpO2 97.00 (96.00, 98.00) 97.00 (96.00, 98.00)
Influenza vaccine 1632 (40%) 414 (39%)
Fever 2258 (44%) 531 (41%)
Fatigue 1456 (28%) 356 (27%)
Occasional Cough 420 (8.1%) 96 (7.4%)
Dry cough 2370 (46%) 594 (46%)
Phlegm cough 641 (12%) 154 (12%)
Running nose 1059 (20%) 290 (22%)
Sore throat 1173 (23%) 293 (23%)
Diarrhea 733 (14%) 206 (16%)
Dyspnea 1822 (35%) 435 (34%)
Anorexia 580 (11%) 128 (9.9%)
Headache 1851 (36%) 461 (36%)
Myalgia 1597 (31%) 386 (30%)
Nausea and vomiting 652 (13%) 174 (13%)
Chest wheezing 120 (2.3%) 27 (2.1%)
Chest pain 889 (17%) 237 (18%)
Abdominal pain 295 (5.7%) 59 (4.6%)
Anosmia 959 (19%) 254 (20%)
Dysgeusia 960 (19%) 247 (19%)
Chills 570 (11%) 148 (11%)
Hypertension 1193 (23%) 266 (20%)
Heart disease 238 (4.6%) 57 (4.4%)
Diabetes mellitus 466 (9.0%) 139 (11%)
Cerebrovascular disease 47 (0.9%) 12 (0.9%)
Chronic kidney disease 188 (3.6%) 40 (3.1%)
Immunosuppression 231 (4.5%) 54 (4.2%)
COPD 84 (1.6%) 24 (1.8%)
Asthma 307 (5.9%) 67 (5.2%)
Tuberculosis 29 (0.6%) 16 (1.2%)
Respiratory disease 79 (1.5%) 20 (1.5%)
Neoplasia 97 (1.9%) 22 (1.7%)
Transplant 171 (3.3%) 37 (2.8%)
Obesity 284 (5.5%) 77 (5.9%)
Smoking 535 (10%) 131 (10%)
Pregnant 61 (1.2%) 21 (1.6%)
Prior hospitalization 47 (0.9%) 13 (1.0%)
Hospitalization 592 (10%) 148 (10%)

Continuous values are present in medians and percentiles (25 and 75%). SpO2: oxyhemoglobin saturation by pulse oximetry; COPD: chronic obstructive pulmonary disease.